Innventure, Inc. (INV) is an Orlando-based venture builder that founds, funds, and operates companies around sustainable technologies licensed from multinationals; its most important holding is Accelsius, which makes two-phase, direct-to-chip liquid cooling for AI data centers. In Wednesday trading, the stock was quoted at $0.1249, down 6.93% from the previous session's close of $0.1342, giving back part of Tuesday's 13.25% rally. The session range ran from $0.1180 to $0.1343, and the move lower came with no fresh press release, SEC filing, or analyst revision. Direction: down.
No verified news or fundamental catalyst found that was published on the day of the decline. The most plausible explanation is technical: Tuesday's bounce off a 52-week low of $0.1011 was sharp and unsupported by new information, so it invited profit-taking once the price stalled at the $0.1340 area — the same level that capped the prior session. The assessment is consistent with a thin order book in a micro-cap trading near $0.12, where modest sell interest moves the tape: roughly 140,000 shares had changed hands by late morning, far below the 20-day average near 2.6 million. It is also consistent with the stock's habit of very large swings — its average absolute daily move over the last 60 sessions is about 9.1%, and 32 of those sessions were at least as large as today's.
The bigger story remains the Nov. 12 third-quarter report, which reset expectations. Revenue of $1.48 million missed consensus of about $6.81 million, and the loss per share of $2.39 included a $323.5 million non-cash goodwill impairment tied largely to Accelsius — a write-down triggered by the collapse in the share price rather than a change in the technology view. Management said most of the $26.95 million in consolidated cash sits at Accelsius, leaving near-term liquidity needs at the parent, which is targeting roughly $3.2 million in quarterly parent-level cash costs after cutting headcount from 40 to 15. A strategic review committee working with RBC Capital Markets is evaluating debt restructuring and partial or full monetization of operating-company stakes. A $60 million at-the-market program, established Oct. 6, keeps dilution risk live at a share price near $0.12.
Layered on top: Nasdaq's Oct. 23 notice that the stock had traded below $1.00 for 30 consecutive business days, with a 180-day cure window to April 21, 2027; ongoing securities class actions over the DarkNX cooling project that was removed from bookings in August; and Roth Capital's Nov. 16 cut of its price target to $1.50 from $6 while keeping a Buy rating. None of these is new, but together they explain why buyers have been unwilling to defend rallies.
Volume was light rather than panicked, running well below the stock's recent pace, which suggests an absence of bids and position unwinding rather than institutional distribution. The move diverged from the AI-infrastructure complex, where NVDA rose after strong results and lifted related data-center names, while small-cap benchmarks were little changed. Technically, the stock remains far below its 50-day moving average near $0.44 and its 200-day average near $3.31, with a 14-day RSI around 28 — oversold, but in a sustained downtrend. Market capitalization is roughly $13 million on about 104.7 million shares, against a 52-week range of $0.1011 to $7.86.
The score runs from 0, meaning no meaningful news and a move that is normal for the stock, to 100, meaning transformative news and an extreme, rare price move. This event lands at 7 out of 100. There was no verified news on the day; the drivers were technical and flow-related, and the most recent fundamental developments had already been public for days. The move was also unremarkable by the stock's own standards — about three-quarters of its 9.1% average daily swing, and smaller than or equal to 32 of the last 60 sessions. Weak news and an ordinary move combine into a low score.
Attention stays on the strategic review: any announcement on debt restructuring, an Accelsius stake sale, or a capital raise would reset the liquidity debate, and continued ATM sales would add supply. Nasdaq compliance is the other clock — the shares need ten consecutive closes at or above $1.00 by April 21, 2027, a path that realistically runs through a reverse split. Investors also face fourth-quarter results, likely in March, with consensus still well above recent run rates, plus broader AI-capex sentiment, litigation milestones, and FOMC minutes and rate expectations that affect appetite for unprofitable micro-caps. Risks run both ways: financing could relieve pressure, but dilution and listing risk remain unresolved.
Tickeron offers hundreds of AI trading bots spanning thousands of tickers, but only the strongest performers under current market conditions appear in the curated Trending AI Robots section. Bots differ by strategy, timeframe, performance metrics, and the symbols they trade, so the featured list changes as market conditions rotate. For traders who want to see which automated approaches are working right now — including on volatile small caps like this one — reviewing the current lineup is a practical first step.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The Aroon Indicator for INV entered a downward trend on November 11, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 144 similar instances where the Aroon Indicator formed such a pattern. In 130 of the 144 cases the stock moved lower. This puts the odds of a downward move at 90%.
The Momentum Indicator moved below the 0 level on October 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on INV as a result. In 47 of 94 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 50%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where INV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 10 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +8.33% 3-day Advance, the price is estimated to grow further. Considering data from situations where INV advanced for three days, in 70 of 144 cases, the price rose further within the following month. The odds of a continued upward trend are 49%.
INV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 6 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 68 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.056) is normal, around the industry mean (2.423). P/E Ratio (-0.102) is within average values for comparable stocks, (8.341). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.318). Dividend Yield (0.000) settles around the average of (0.274) among similar stocks. P/S Ratio (13.316) is also within normal values, averaging (15.906).
The Tickeron Price Growth Rating for this company is 98 (best 1 - 100 worst), indicating slightly worse than average price growth. INV’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. INV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry InvestmentManagers